Hoegl L, Thoma-Greber E, Röcken M
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München.
Hautarzt. 1996 Jan;47(1):58-61. doi: 10.1007/s001050050376.
A HIV-infected patient in stage CDC 3A with porphyria cutanea tarda (type I) was treated with chloroquin for some months and this led to full remission. The patient course is compared with earlier reports on HIV-infected patients with porphyria cutanea tarda. Possible provocation factors for porphyria cutanea tarda in HIV infection are considered. The increased prevalence of porphyria cutanea tarda in HIV infection, the interaction of HIV and UV irradiation as a prediposing factor for porphyria cutanea tarda and the photosensitivity present in HIV infection are discussed.
一名处于美国疾病控制与预防中心（CDC）3A期的人类免疫缺陷病毒（HIV）感染患者，患有迟发性皮肤卟啉症（I型），接受了数月的氯喹治疗，结果完全缓解。将该患者的病程与先前关于HIV感染合并迟发性皮肤卟啉症患者的报告进行了比较。探讨了HIV感染中迟发性皮肤卟啉症可能的激发因素。讨论了HIV感染中迟发性皮肤卟啉症患病率的增加、HIV与紫外线照射作为迟发性皮肤卟啉症的前置因素的相互作用以及HIV感染中存在的光敏性。
